Literature DB >> 1416874

Primary and secondary metabolism of pentamidine by rats.

B J Berger1, N A Naiman, J E Hall, J Peggins, T G Brewer, R R Tidwell.   

Abstract

The antiprotozoal drug pentamidine [1,5-bis(4'-amidinophenoxy)pentane] has been previously shown to be metabolized by rat liver microsomes, and five of the seven putative primary metabolites have been identified. With the synthesis and identification of 5-(4'-amidinophenoxy)pentanoic acid and 5-(4'-amidinophenoxy)-1-pentanol as the remaining two metabolites, the primary metabolism of pentamidine in rats appears fully characterized. Use of [14C]pentamidine with rat liver microsomes confirms this conclusion, since no unidentified radioactive peaks were detected by high-performance liquid chromatography (HPLC). Isolated, perfused rat livers were used with [14C]pentamidine to identify secondary metabolites. Only two novel radioactive peaks were detected by HPLC analysis of perfused liver samples. The treatment of liver samples with sulfatase or beta-glucuronidase resulted in the reduction or elimination of these peaks and gave rise to peaks identified as para-hydroxybenzamidine and 5-(4'-amidinophenoxy)pentanoic acid. It was concluded from these results that only these two primary metabolites were conjugated with sulfate or glucuronic acid. After 4 h of incubation in the perfused liver system, approximately 15% of the recovered radiolabel was pentamidine. These results suggest that pentamidine metabolism can be rapid and extensive in rats.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1416874      PMCID: PMC192194          DOI: 10.1128/AAC.36.9.1825

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  [Study of the accumulation and the elimination of pentamidine in the mouse and the white rat].

Authors:  L LAUNOY; M GUILLOT; H JONCHERE
Journal:  Ann Pharm Fr       Date:  1960-06

2.  [Study of the storage and elimination of pentamidine in the mouse and white rat].

Authors:  L LAUNOY; M GUILLOT; H JONCHERE
Journal:  Ann Pharm Fr       Date:  1960-05

3.  Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features.

Authors:  P D Walzer; D P Perl; D J Krogstad; P G Rawson; M G Schultz
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

4.  Canalicular bile flow and bile secretory pressure. Evidence for a non-bile salt dependent fraction in the isolated perfused rat liver.

Authors:  J L Boyer; G Klatskin
Journal:  Gastroenterology       Date:  1970-12       Impact factor: 22.682

Review 5.  The isolated perfused rat liver: conceptual and practical considerations.

Authors:  G J Gores; L J Kost; N F LaRusso
Journal:  Hepatology       Date:  1986 May-Jun       Impact factor: 17.425

6.  Biochemical and ultrastructural evaluation of isolated rat liver systems perfused with a hemoglobin-free medium.

Authors:  T Sugano; K Suda; M Shimada; N Oshino
Journal:  J Biochem       Date:  1978-04       Impact factor: 3.387

7.  Hydroxylation of pentamidine by rat liver microsomes.

Authors:  B J Berger; V V Reddy; S T Le; R J Lombardy; J E Hall; R R Tidwell
Journal:  J Pharmacol Exp Ther       Date:  1991-03       Impact factor: 4.030

8.  Concentrations of aerosolized pentamidine in bronchoalveolar lavage, systemic absorption, and excretion.

Authors:  J E Conte; J A Golden
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

Review 9.  Pentamidine: a review.

Authors:  M Sands; M A Kron; R B Brown
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

10.  High-performance liquid chromatographic method for quantitation of pentamidine in blood serum.

Authors:  C M Dickinson; T R Navin; F C Churchill
Journal:  J Chromatogr       Date:  1985-11-29
View more
  13 in total

Review 1.  Antiparasitic compounds that target DNA.

Authors:  W David Wilson; Farial A Tanious; Amanda Mathis; Denise Tevis; James Edwin Hall; David W Boykin
Journal:  Biochimie       Date:  2008-03-04       Impact factor: 4.079

2.  Immunoassays for pentamidine and related compounds: development of a facile inhibitory ELISA suitable for clinical use.

Authors:  H M Reisner; D R Gray; S K Jones; B G Rose; R R Tidwell
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 3.  Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia.

Authors:  H F Vöhringer; K Arastéh
Journal:  Clin Pharmacokinet       Date:  1993-05       Impact factor: 6.447

4.  Pharmacokinetic comparison to determine the mechanisms underlying the differential efficacies of cationic diamidines against first- and second-stage human African trypanosomiasis.

Authors:  Sihyung Yang; Tanja Wenzler; Patrik N Miller; Huali Wu; David W Boykin; Reto Brun; Michael Zhuo Wang
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

5.  Anti-Pneumocystis activities of aromatic diamidoxime prodrugs.

Authors:  J E Hall; J E Kerrigan; K Ramachandran; B C Bender; J P Stanko; S K Jones; D A Patrick; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

6.  Pharmacokinetics and adverse reactions after a single dose of pentamidine in patients with Trypanosoma gambiense sleeping sickness.

Authors:  U Bronner; L L Gustafsson; F Doua; O Ericsson; T Miézan; M Rais; L Rombo
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

Review 7.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

Review 8.  Novel amidines and analogues as promising agents against intracellular parasites: a systematic review.

Authors:  M N C Soeiro; K Werbovetz; D W Boykin; W D Wilson; M Z Wang; A Hemphill
Journal:  Parasitology       Date:  2013-04-08       Impact factor: 3.234

9.  Structure-in vitro activity relationships of pentamidine analogues and dication-substituted bis-benzimidazoles as new antifungal agents.

Authors:  M Del Poeta; W A Schell; C C Dykstra; S Jones; R R Tidwell; A Czarny; M Bajic; A Kumar; D Boykin; J R Perfect
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

10.  Effects of pentamidine isethionate on Saccharomyces cerevisiae.

Authors:  G Ludewig; J M Williams; Y Li; C Staben
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.